G, S., K, M., & KR, A. (2026). Neuro-renin-angiotensin-aldosterone system axis in alzheimer's disease: From molecular dysregulation to therapeutic redirection. Metabolic brain disease, 41(1), 36. https://doi.org/10.1007/s11011-025-01780-x
Chicago Style (17th ed.) CitationG, Singh, Maparu K, and Aran KR. "Neuro-renin-angiotensin-aldosterone System Axis in Alzheimer's Disease: From Molecular Dysregulation to Therapeutic Redirection." Metabolic Brain Disease 41, no. 1 (2026): 36. https://doi.org/10.1007/s11011-025-01780-x.
MLA (9th ed.) CitationG, Singh, et al. "Neuro-renin-angiotensin-aldosterone System Axis in Alzheimer's Disease: From Molecular Dysregulation to Therapeutic Redirection." Metabolic Brain Disease, vol. 41, no. 1, 2026, p. 36, https://doi.org/10.1007/s11011-025-01780-x.